human albumin = human bioplazma solution for infusion
human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions
human albumin 20% biotest low salt content
biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human plasma, protein - solution for infusion - human plasma protein 200 g/l - blood substitutes and perfusion solutions
albumin novo nordisk injectable solution 50 mg/ml
wael pharmacy - human serum albuminum (125 i) - injectable solution - 50
albumin novo nordisk injectable solution 50 mg/ml
wael pharmacy - human serum albuminum (125 i) - injectable solution - 50
albumin novo nordisk injectable solution 200 mg/ml (20%)
wael pharmacy - human serum albuminum (125 i) - injectable solution - 200
albumin novo nordisk injectable solution 200 mg/ml (20%)
wael pharmacy - human serum albuminum (125 i) - injectable solution - 200
human albumin 20% solution for infusion
human bioplazma llc, hungary - albumin human - solution - 20 %
human albumin 20% solution for infusion
human bioplazma llc, hungary - albumin human - solution - 20 %
human albumin 20% infusion
human albumin 20% - infusion - human albumin 20% - albumin
octagam normal immunoglobulin (human) 20g/200ml solution for intravenous infusion
octapharma australia pty ltd - human immunoglobulin g, quantity: 100 mg/ml - injection - excipient ingredients: octoxinol 10; maltose; tributyl phosphate; water for injections; human immunoglobulin a - replacement therapy in: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulation: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.